相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The pathomimetic oAl325-35 model of Alzheimer's disease: Potential for screening of new therapeutic agents
Geoffrey Canet et al.
PHARMACOLOGY & THERAPEUTICS (2023)
Chronic Glucocorticoids Consumption Triggers and Worsens Experimental Alzheimer's Disease-Like Pathology by Detrimental Immune Modulations
Geoffrey Canet et al.
NEUROENDOCRINOLOGY (2022)
Overcoming undesirable hERG affinity by incorporating fluorine atoms: A case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c] quinolines
Katarzyna Grychowska et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
GPCRs steer Gi and Gs selectivity via TM5-TM6 switches as revealed by structures of serotonin receptors
Sijie Huang et al.
MOLECULAR CELL (2022)
Cdk5-p25 as a key element linking amyloid and tau pathologies in Alzheimer's disease: Mechanisms and possible therapeutic interventions
Subhamita Maitra et al.
LIFE SCIENCES (2022)
Monoamine Oxidase-B (MAO-B) Inhibitors in the Treatment of Alzheimer's and Parkinson's Disease
Zeynep Ozdemir et al.
CURRENT MEDICINAL CHEMISTRY (2021)
Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties
Pawel Zajdel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Treatments for Alzheimer's disease emerge
Dennis J. Selkoe
SCIENCE (2021)
Glucocorticoid receptors signaling impairment potentiates amyloid-beta oligomers-induced pathology in an acute model of Alzheimer's disease
Geoffrey Canet et al.
FASEB JOURNAL (2020)
The 5-HT6 receptor interactome: New insight in receptor signaling and its impact on brain physiology and pathologies
Severine Chaumont-Dubel et al.
NEUROPHARMACOLOGY (2020)
Early 5-HT6 receptor blockade prevents symptom onset in a model of adolescent cannabis abuse
Coralie Berthoux et al.
EMBO MOLECULAR MEDICINE (2020)
Dual Target Ligands with 4-tert-Butylphenoxy Scaffold as Histamine H3 Receptor Antagonists and Monoamine Oxidase B Inhibitors
Dorota Lazewska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Binding of Palonosetron and Other Antiemetic Drugs to the Serotonin 5-HT3 Receptor
Eleftherios Zarkadas et al.
STRUCTURE (2020)
mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment
Pierre-Yves Martin et al.
PROGRESS IN NEUROBIOLOGY (2020)
A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties
Vittorio Canale et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease
Jong-Hyun Park et al.
SCIENCE ADVANCES (2019)
Computational Insight into the Mechanism of the Irreversible Inhibition of Monoamine Oxidase Enzymes by the Antiparkinsonian Propargylamine Inhibitors Rasagiline and Selegiline
Tana Tandaric et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Novel non-sulfonamide 5-HT6 receptor partial inverse agonist in a group of imidazo[4,5-b]pyridines with cognition enhancing properties
David Vanda et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Serotonin 5-HT6 Receptor Antagonists in Alzheimer's Disease: Therapeutic Rationale and Current Development Status
Hilda Ferrero et al.
CNS DRUGS (2017)
Modulating 5-HT4 and 5-HT6 receptors in Alzheimer's disease treatment
Julien Lalut et al.
FUTURE MEDICINAL CHEMISTRY (2017)
OPLS3: A Force Field Providing Broad Coverage of Drug-like Small Molecules and Proteins
Edward Harder et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2016)
Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease
Katarzyna Grychowska et al.
ACS CHEMICAL NEUROSCIENCE (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
New selective glucocorticoid receptor modulators reverse amyloid-β peptide-induced hippocampus toxicity
Fanny Pineau et al.
NEUROBIOLOGY OF AGING (2016)
Physical interaction between neurofibromin and serotonin 5-HT6 receptor promotes receptor constitutive activity
Wissem Deraredj Nadim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Indazole- and Indole-5-carboxamides: Selective and Reversible Monoamine Oxidase B Inhibitors with Subnanomolar Potency
Nikolay T. Tzvetkov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth
Fanny Duhr et al.
NATURE CHEMICAL BIOLOGY (2014)
Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment
Cedric Lecoutey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Tropisetron attenuates amyloid-beta-induced inflammatory and apoptotic responses in rats
Reza Rahimian et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2013)
Dual Targeting of Adenosine A2A Receptors and Monoamine Oxidase B by 4H-3,1-Benzothiazin-4-ones
Anne Stoessel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Deregulation of hypothalamic-pituitary-adrenal axis functions in an Alzheimer's disease rat model
Anthony Brureau et al.
NEUROBIOLOGY OF AGING (2013)
Alzheimer's Disease Related Markers, Cellular Toxicity and Behavioral Deficits Induced Six Weeks after Oligomeric Amyloid-β Peptide Injection in Rats
Charleine Zussy et al.
PLOS ONE (2013)
OPM database and PPM web server: resources for positioning of proteins in membranes
Mikhail A. Lomize et al.
NUCLEIC ACIDS RESEARCH (2012)
Time-Course and Regional Analyses of the Physiopathological Changes Induced after Cerebral Injection of an Amyloid β Fragment in Rats
Charleine Zussy et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
NCIPLOT: A Program for Plotting Noncovalent Interaction Regions
Julia Contreras-Garcia et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2011)
A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu
Stefan Grimme et al.
JOURNAL OF CHEMICAL PHYSICS (2010)
MECHANISMS OF DISEASE Alzheimer's Disease
Henry W. Querfurth et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Epik:: a software program for pK a prediction and protonation state generation for drug-like molecules
John C. Shelley et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)
Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia:: Autoantibodies to Aβ(25-35) oligomers, S100b and neurotransmitters
Marina A. Gruden et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Use of a cAMP BRET sensor to characterize a novel regulation of cAMP by the sphingosine 1-phosphate/G13 pathway
Lily I. Jiang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Modulation of dopamine transmission by 5HT2c and 5HT3 receptors:: A role in the antidepressant response
E Dremencov et al.
CURRENT DRUG TARGETS (2006)
Binding of rasagiline-related inhibitors to human monoamine oxidases. a kinetic and crystallographic analysis
C Binda et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Activation of presynaptic 5-HT3 receptors facilities glutamatergic synaptic inputs to area postrema neurons in rat brain slices
M Funahashi et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2004)
Calcium influx through presynaptic 5-HT3 receptors facilitates GABA release in the hippocampus: in vitro slice and synaptosome studies
TJ Turner et al.
NEUROSCIENCE (2004)
Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders
C Binda et al.
NATURE STRUCTURAL BIOLOGY (2002)
Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's Aβ(1-42) and Aβ(25-35)
S Varadarajan et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2001)
Drastic neuronal loss in vivo by beta-amyloid racemized at Ser(26) residue: conversion of non-toxic [D-Ser(26)]beta-amyloid 1-40 to toxic and proteinase-resistant fragments
I Kaneko et al.
NEUROSCIENCE (2001)
Animal models of Alzheimer's disease and evaluation of anti-dementia drugs
K Yamada et al.
PHARMACOLOGY & THERAPEUTICS (2000)
分享论文
